UASt regulatory sequences drive expression of an inverted repeat.
The cell size in pupal (2hr after pupariation) midgut somatic clones expressing TSG101GD14295 under the control of Scer\GAL4Scer\FRT.Rnor\Cd2.Act5C is significantly increased but the cells contain fewer Atg8a puncta compared to control cells.
The expression of TSG101GD14295 under the control of Scer\GAL4c564 does not lead to significant changes in the average adult fat body cell size, as compared to controls.
Expression of Scer\GAL4C-765>TSG101GD14295 does not induce any obvious abnormalities.
Expression under the control of Scer\GAL4Mef2.PR results in late pupal lethality.
TSG101GD14295/Scer\GAL4C-765 is an enhancer of visible phenotype of Scer\GAL4C-765, smoPKA12.UAS
TSG101GD14295/Scer\GAL4C-765 is an enhancer of wing vein L3 phenotype of Scer\GAL4C-765, smoPKA12.UAS
TSG101GD14295/Scer\GAL4C-765 is an enhancer of wing vein L4 phenotype of Scer\GAL4C-765, smoPKA12.UAS
The co-expression of TSG101GD14295 and pnutGD1512 from the second instar larval stage under the combined control of Scer\GAL4ap-md544 and Gal80[ts] does not leads to the formation of tumors in the third instar larval wing disc.
Co-expression of TSG101GD14295 with smoPKA12.Scer\UAS under the control of Scer\GAL4C-765 enhances the wing vein fusion phenotype resulting from the expression of smoPKA12.Scer\UAS.